Welcoming WA Department of Health to CT:IQ Steering Committee 

We are excited to announce that the WA Department of Health, Office of Medical Research and Innovation (OMRI) has joined the CT:IQ Steering Committee! OMRI brings a wealth of expertise in policy and funding support for health and medical research and innovation in Western Australia. OMRI’s key functions include: Guiding, informing, and promoting collaboration across […]

CT:IQ unveils innovative PICF for Australian health and medical research

CT:IQ has successfully launched an ambitious project to create a concise, participant-centred Participant Information and Consent Form (PICF) tailored for Australian health and medical research. Since February 2021, a committed group of 35 project team members from across the sector worked alongside CT:IQ Project Manager, Sonia Harvey, to bring this vision to fruition. The comprehensive […]

CT:IQ welcomes newest member, GenesisCare

CT:IQ welcomes integrated cancer care provider, GenesisCare, to our diverse and growing Steering Committee. GenesisCare aims to change the face of cancer care with modern treatments and techniques designed to achieve the best possible life outcomes for patients. They pride themselves on offering dedicated multidisciplinary patient care, working to develop a deep understanding of patient […]

Mapping the DCT Landscape

CT:IQ is pleased to release the report prepared by Dr Tanya Symons – A mapping exercise to identify initiatives to support the implementation of decentralised clinical trials including teletrials in Australia (December 2023). This report stemmed from discussions at the August 2023 CT:IQ Steering Committee meeting, where members identified mapping the teletrials and DCT landscape […]

Welcoming HMRI to CT:IQ’s Steering Committee

We are thrilled to announce that the Hunter Medical Research Institute (HMRI) has joined CT:IQ as a valued member of our Steering Committee. HMRI exists to transform the health and wellbeing of their communities. They discover local and cure global with a vision to create the healthiest million people for the planet. Committed to radical […]

Highly Commended Consumer Involvement Paper

CT:IQ and the Australian Clinical Trials Alliance (ACTA) are pleased to announce a prestigious award for an innovative coauthored publication that focused on their development of a toolkit to support meaningful consumer involvement in clinical trials in Australia. The paper, titled ‘Development of the Consumer Involvement & Engagement Toolkit: a digital resource to build capacity […]

CT:IQ Welcomes NT Health to Steering Committee

We are pleased to welcome CT:IQ’s first representative from Northern Territory to join our Steering Committee: NT Health. NT Health manages the Northern Territory public health system, operating across five service delivery regions, six hospitals, 74 health clinics and seven corporate offices. NT Health works together as one system in partnership with individuals, families, the community, […]

CT:IQ welcomes newest Steering Committee Member, Fortrea

CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee. Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing […]

ObvioHealth joins CT:IQ Steering Committee

CT:IQ is thrilled to announce our newest Steering Committee member, ObvioHealth. ObvioHealth, a virtual research organisation (VRO), brings a wealth of experience and expertise in conducting decentralised clinical trials (DCTs) that produce stronger therapeutic evidence. Its mission is to conduct innovative and efficient trials using technology to capture more robust and accurate data—so life-improving innovations […]